| 1 |
34495376 | Rivaroxaban compared with low-dose aspirin in individuals with type 2 diabetes and high cardiovascular risk: a randomised trial to assess effects on endothelial function, platelet activation and vascular biomarkers. | 2021 Dec |
1 |
| 2 |
32523458 | Rivaroxaban in patients with ischaemic chronic cardiomyopathy and obstructive peripheral arterial disease: rationale for treatment and results. | 2020 Jun |
1 |
| 3 |
32755422 | Aspirin and low-dose rivaroxaban - the dual pathway concept in patients with stable atherosclerotic disease: a comprehensive review. | 2020 Sep |
1 |
| 4 |
29525076 | Characterization of Patients with Embolic Strokes of Undetermined Source in the NAVIGATE ESUS Randomized Trial. | 2018 Jun |
1 |
| 5 |
29766772 | Rivaroxaban for Stroke Prevention after Embolic Stroke of Undetermined Source. | 2018 Jun 7 |
1 |
| 6 |
23615159 | The effects of the antiplatelet agents, aspirin and naproxen, on pharmacokinetics and pharmacodynamics of the anticoagulant edoxaban, a direct factor Xa inhibitor. | 2013 Aug |
2 |